Article Details
Retrieved on: 2023-11-19 19:22:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The firm set a “buy” rating and a $26.00 price target on the biotechnology company's stock. Truist Financial's target price points to a potential ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here